Abiopharma

🔍 McDermott William R (Director)

Company: ServiceNow, Inc. (NOW)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Acquired 8,765 shares of Common Stock (Direct)
  Date: 2026-05-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 166,999.00 | transaction_form_type: 4
• Sold 4,712 shares of Common Stock at $93.59 per share (Direct)
  Date: 2026-05-07 | Code: F | equity_swap_involved: 0 | shares_owned_after: 162,287.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-07 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 24,405.00
• Sold 8,765 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 17,540.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3

Footnotes:

• F1: Represents shares relinquished by the Reporting Person in exchange for the Issuer's payment of federal and state tax withholding obligations of the Reporting Person resulting from the vesting of RSUs, in accordance with Rule 16b-3.
• F2: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
• F3: 3.33% of the shares subject to the restricted stock units vested on each of May 7, 2024, and August 7, 2024, 3.34% of the shares subject to the restricted stock units vested on November 7, 2024, and the remaining 90% of the shares subject to the restricted stock units began vesting quarterly on February 7, 2025, and subject to the reporting person's continued service to the Issuer on each vesting date.